SS Innovations International Inc Common Stock (SSII) had the highest return between November 1, 2022 and December 30, 2022 by a mid-cap US stock, returning 12,369.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
SS Innovations International Inc Common Stock (SSII) | 11/1/2022 - 12/30/2022 | 12,369.14% |
Madrigal Pharmaceuticals (MDGL) | 11/1/2022 - 12/30/2022 | 301.56% |
Bilibili (BILI) | 11/1/2022 - 12/30/2022 | 142.23% |
Viking Therapeutics (VKTX) | 11/1/2022 - 12/30/2022 | 125.96% |
GDS (GDS) | 11/1/2022 - 12/30/2022 | 106.2% |
F&G Annuities & Life (FG) | 11/1/2022 - 12/30/2022 | 100.1% |
Soleno Therapeutics (SLNO) | 11/1/2022 - 12/30/2022 | 100% |
Verona Pharma PLC ADR (VRNA) | 11/1/2022 - 12/30/2022 | 97.95% |
TG Therapeutics (TGTX) | 11/1/2022 - 12/30/2022 | 97.83% |
Miniso Group Holding (MNSO) | 11/1/2022 - 12/30/2022 | 97.24% |
Melco Resorts & Entertainment (MLCO) | 11/1/2022 - 12/30/2022 | 91.03% |
360 DigiTech (QFIN) | 11/1/2022 - 12/30/2022 | 90.24% |
Vipshop (VIPS) | 11/1/2022 - 12/30/2022 | 79.24% |
Manchester United (MANU) | 11/1/2022 - 12/30/2022 | 75.94% |
Kanzhun Ltd ADR (BZ) | 11/1/2022 - 12/30/2022 | 73.22% |
IAMGold (IAG) | 11/1/2022 - 12/30/2022 | 73.15% |
Axsome Therapeutics (AXSM) | 11/1/2022 - 12/30/2022 | 67.67% |
Alvotech (ALVO) | 11/1/2022 - 12/30/2022 | 66.39% |
RLX Technology (RLX) | 11/1/2022 - 12/30/2022 | 59.73% |
HUTCHMED DRC (HCM) | 11/1/2022 - 12/30/2022 | 58.92% |
Immunovant (IMVT) | 11/1/2022 - 12/30/2022 | 57.5% |
Weibo (WB) | 11/1/2022 - 12/30/2022 | 57.37% |
VEON (VEON) | 11/1/2022 - 12/30/2022 | 57% |
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW) | 11/1/2022 - 12/30/2022 | 55.58% |
Roivant Sciences (ROIV) | 11/1/2022 - 12/30/2022 | 53.95% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
